Clinical trial
A Prospective, Multi-Center, Non-Randomized, Single-Arm Trial to Evaluate the Safety and Feasibility of the TriMaxx Coronary Stent in de Novo Coronary Artery Lesions.
NCT00596661 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-Center, Non-Randomized, Single-Arm Trial to Evaluate the Safety and Feasibility of the TriMaxx Coronary Stent in de Novo Coronary Artery Lesions.
- Lead sponsor
- Abbott Medical Devices
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2004
- Completion date
- September 30, 2005
- Enrollment
- 100 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.